Codes / ICD10CM / K71.7

K71.7 Toxic liver disease with fibrosis and cirrhosis of liver

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Liver Disease with Fibrosis and Cirrhosis of Liver (ICD-10 Code: K71.7)

Summary

Toxic liver disease with fibrosis and cirrhosis of the liver is a condition characterized by progressive liver damage due to exposure to harmful substances, leading to the formation of scar tissue (fibrosis) and advanced scarring (cirrhosis). This impairs liver function and may result in long-term complications.

Causes

The condition is caused by prolonged or repeated exposure to hepatotoxic agents, including certain medications, chemicals, or environmental toxins. These substances trigger chronic inflammation and cellular damage, leading to fibrosis and eventual cirrhosis over time.

Risk Factors

  • Prolonged or high-dose use of hepatotoxic drugs
  • Chronic excessive alcohol consumption
  • Occupational or environmental exposure to chemicals
  • Pre-existing liver conditions that reduce metabolic capacity
  • Genetic factors affecting drug metabolism

Symptoms

  • Jaundice (yellowing of skin or eyes)
  • Dark urine
  • Abdominal pain (especially upper right quadrant)
  • Fatigue and weakness
  • Nausea or vomiting
  • Loss of appetite
  • Swelling in the abdomen or legs
  • Easy bruising or bleeding

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests (e.g., liver function tests, bilirubin levels), imaging studies (e.g., ultrasound or MRI), and sometimes liver biopsy to assess fibrosis and cirrhosis. A thorough history of substance exposure is critical for identifying the cause.

Treatment Options

  • Discontinuation of the toxic substance or drug
  • Medications to manage symptoms (e.g., diuretics for swelling)
  • Nutritional support and dietary modifications
  • Management of complications (e.g., variceal bleeding, ascites)
  • In severe cases, liver transplantation may be considered

Prognosis and Follow-Up

Prognosis depends on the extent of liver damage, the ability to remove the toxic exposure, and response to treatment. Regular follow-up with liver function monitoring and imaging is essential to assess disease progression and manage complications.

Complications

  • Liver failure
  • Portal hypertension
  • Variceal bleeding
  • Ascites (fluid buildup in the abdomen)
  • Hepatic encephalopathy
  • Increased risk of liver cancer

Lifestyle & Prevention

  • Avoid or limit alcohol consumption
  • Use medications only as prescribed and avoid hepatotoxic drugs when possible
  • Follow safety guidelines for handling chemicals or toxins
  • Maintain a balanced diet and healthy weight
  • Vaccinate against hepatitis A and B to prevent additional liver damage

When to Seek Professional Help

Seek immediate medical attention if you experience severe abdominal pain, jaundice, confusion, or signs of bleeding. Regular check-ups are recommended for those with known toxic exposure or pre-existing liver conditions.

Tips for Medical Coders

Document the underlying toxic exposure (e.g., drug, chemical) and the extent of liver damage (fibrosis, cirrhosis) to support code assignment. Ensure clinical correlation between the toxic agent and liver findings, as coding requires specificity about the condition's etiology and manifestations.

Book a walkthrough

K71.7 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.